Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Congenital Heart Disease (CHD) Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_
In recent times, the size of the congenital heart disease (chd) market has exhibited significant growth. The growth is expected to continue, with market size predicted to rise from $4.42 billion in 2024 to $4.85 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. The growth observed in the past can be credited to factors like the rise in the prevalence of risk factors such as obesity and smoking, advancements in diagnostic technologies, an increase in the aged population, intensified awareness campaigns, improved reimbursement policies, and a boost in investment towards research and development._x000D_
_x000D_
The market for congenital heart disease (chd) is predicted to experience substantial growth in the approaching years, expanding to$6.82 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. The market expansion during the forecast period is attributed to the broadening of healthcare services in emergent regions, enduring improvements in heart imaging technology, growing campaigns that advocate for early detection and treatment, an increase in global healthcare spending, and advances in personalized medicine. The forecast period will also see trends such as the emerging use of less invasive surgical procedures, the growing role of telemedicine in remotely monitoring patients and consultations, an increased demand for personalized treatment methods, the emergence of innovative implantable devices with improved features and lifespan, and the incorporation of artificial intelligence and machine learning into diagnostic and therapeutic procedures._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp_x000D_
_x000D_
#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Congenital Heart Disease (CHD) Market?#_x000D_
The surge in cases of maternal diabetes is projected to fuel expansion in the congenital heart disease (CHD) market. Maternal diabetes, also known as gestational diabetes mellitus (GDM), is a form of diabetes that emerges during pregnancy in women who were not previously diabetic. Lifestyle changes like inactive behavior, unhealthy eating habits, and a general rise in obesity rates among women within the reproductive age are the triggers of maternal diabetes. This condition can result in congenital heart disease (CHD) in newborns due to high maternal blood sugar levels interfering with normal fetal heart development. High glucose levels in a mother’s blood can interrupt standard heart development in the fetus, thus raising the chance of CHD. For example, data from the UK’s National Health Service in October 2023 showed an upswing in adverse pregnancy outcomes for women diagnosed with type 2 diabetes in 2021 from 4.9% to 6.6% in 2022. Hence, the prevalence of maternal diabetes is amplifying the growth of the congenital heart disease (CHD) market._x000D_
_x000D_
#Which Key Market Segments Comprise the Congenital Heart Disease (CHD) Market and Drive Its Revenue Growth?#_x000D_
The congenital heart disease (chd)market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types_x000D_
2) By Diagnosis: Electrocardiogram; Chest X-ray; Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis_x000D_
3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications_x000D_
4) By Age Group: Infants; Children; Adolescents; Adults_x000D_
5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions_x000D_
_x000D_
Subsegments:_x000D_
1) By Heart Valve Defects: Aortic Valve Stenosis; Pulmonary Valve Stenosis; Mitral Valve Prolapse; Tricuspid Valve Defects; Valve Regurgitation _x000D_
2) By Heart Wall Defects: Atrial Septal Defect (ASD); Ventricular Septal Defect (VSD); Atrioventricular Septal Defect (AVSD); Hypoplastic Left Heart Syndrome (HLHS); Tetralogy of Fallot (TOF) _x000D_
3) By Blood Vessel Defects: Coarctation Of The Aorta; Patent Ductus Arteriosus (PDA); Pulmonary Artery Stenosis; Transposition Of The Great Arteries (TGA); Truncus Arteriosus _x000D_
4) By Other Types: Single Ventricle Defects; Ebstein’s Anomaly; Total Anomalous Pulmonary Venous Return (TAPVR); Coronary Artery Anomalies; Pulmonary Venous Obstruction_x000D_
_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=15545&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the Congenital Heart Disease (CHD) Market Expansion Across the Globe?#_x000D_
North America was the largest region in the congenital heart disease (CHD) market in 2024. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Are the Key Market Trends in theCongenital Heart Disease (CHD) Market Over the Coming Years?#_x000D_
Top-tier companies in the congenital heart disease market are innovating and producing non-surgical heart valves to elevate the patient experience and their quality of living. These non-surgical, or transcatheter valves, constitute a significant advancement in cardiac healthcare as they mitigate the requirement for traditional open-heart surgery. For instance, Medtronic, an eminent medical technology firm based in the U.S., revived its Harmony Transcatheter Pulmonary Valve (TPV) System in February 2023. This system offers a groundbreaking, minimally invasive alternative to open-heart surgical procedures specifically for individuals suffering from congenital heart disease, notably those with inherent or surgically repaired anomalies in their right ventricular outflow tract (RVOT). Securing the position of the first FDA-approved valve constructed for the right side, this system serves to provide a non-surgical respite for patients enduring severe pulmonary valve regurgitation. The Harmony TPV System, which initially received FDA approval in 2021, was relaunched post a voluntary recall, exemplifying Medtronic’s dedication to progressing solutions for individuals diagnosed with congenital heart disease._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Congenital Heart Disease (CHD) Market Conceptually Defined?#_x000D_
Congenital heart disease (CHD) refers to a range of birth defects affecting the structure and function of the heart that are present at birth. These defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. The treatment for CHD depends on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15545_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model